Ending Soon! COVID Health Emergency Scheduled to End on May 11, 2023

The Department of Health and Human Services (HHS) is planning for the federal Public Health Emergency for COVID-19, declared under Section 319 of the Public Health Service Act, to expire on May 11, 2023. Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap. The announcement follows the Administration’s January 30, 2023, Statement of Administration Policy announcing its plan to extend both the public health emergency and the national emergency until May 11, 2023. What’s going to be the new normal?

Read now »

Related Content

• Employee Benefit Plan COVID-19 Relief Chart and Tracker
  Reference this chart which summarizes relief issued by the Departments of Labor, Treasury, and Health and Human Services for many time-sensitive and other requirements pertaining to the administration of employee benefit plans due to the disruption caused by the coronavirus pandemic. 

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.   

• Employee Benefits & Executive Compensation Key Legal Developments Tracker
  Stay informed on new developments.
  • Retirement Plans. IRS announces that on or after February 28, 2023, it intends to issue opinion letters for pre-approved defined benefit plans that were (1) restated for changes in plan qualification requirements listed in the 2020 Cumulative List (see Notice 2020-14) and (2) filed with the IRS for the third six-year remedial amendment cycle under Rev. Proc. 2016-37.  Announcement 2023-6.
  • Retirement Plans. Employee Benefits Security Administration proposes program amendments to the prohibited transaction exemption and reopens the comment period in its Voluntary Fiduciary Correction Program. 88 Fed. Reg. 9408 (Feb. 14, 2023).
  • Health and Welfare Plans. HHS releases initial guidance for Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act providing that drug companies will rebate Medicare when their prescription drug prices increase faster than the rate of inflation for certain drugs dispensed to Medicare enrollees. HHS Press Release (Feb. 9, 2023).
  • Health and Welfare Plans. The Federal Trade Commission imposes a fine of $1.5 million against GoodRx for the unauthorized disclosure of consumer health data. FTC Press Release (Feb. 1, 2023).
• Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.
• The Practical Guidance Journal Climate Change Special Edition features guidance on insuring for climate change, renewable energy initiatives, and a guide for public and private projects related to sea level rise.
• Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content. 
• Listen Up! The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more.
• Check out the new Practical Guidance Author Center! Learn about the 1750+ leading attorney authors contributing to our 22 practice areas and find out how you can Become a Practical Guidance Author. 

• New and Updated Practical Guidance Content
  • Adjusted DOL Penalties for Violations of Select ERISA Requirements Chart
  • SECURE 2.0 Act Tracker
  • Top Hat Plans
  • FTC Noncompete Ban Could Open State Litigation Floodgate
  • Evolving Laws and Litigation Post-Dobbs: The State of Reproductive Rights as of January 2023
  • SECURE 2.0 Act of 2022 Passed: Overpayment Provisions Now Effective
  • DOL Opens ESG Door: What Does It Mean for Plan Fiduciaries?
  • Post-Deductible HRAs and Limited Purpose FSAs Video
  • The 7 Biggest Benefits Rulings of 2022

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+